Wells Fargo’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,614
| Closed | -$9K | – | 7980 |
|
|
2022
Q2 | $9K | Buy |
2,614
+2
| +0.1% | +$8 | ﹤0.01% | 5826 |
|
|
2022
Q1 | $11K | Sell |
2,612
-2,499
| -49% | -$10.9K | ﹤0.01% | 6252 |
|
|
2021
Q4 | $24K | Sell |
5,111
-500
| -9% | -$2.08K | ﹤0.01% | 6281 |
|
|
2021
Q3 | $23K | Sell |
5,611
-4,900
| -47% | -$19.4K | ﹤0.01% | 5939 |
|
|
2021
Q2 | $44K | Sell |
10,511
-363,245
| -97% | -$1.56M | ﹤0.01% | 5619 |
|
|
2021
Q1 | $1.58M | Buy |
373,756
+347,503
| +1,324% | +$1.91M | ﹤0.01% | 3899 |
|
|
2020
Q4 | $102K | Sell |
26,253
-16,806
| -39% | -$71.8K | ﹤0.01% | 5356 |
|
|
2020
Q3 | $173K | Sell |
43,059
-8,019
| -16% | -$33.2K | ﹤0.01% | 5025 |
|
|
2020
Q2 | $217K | Buy |
51,078
+8,494
| +20% | +$51.7K | ﹤0.01% | 4866 |
|
|
2020
Q1 | $179K | Buy |
42,584
+810
| +2% | +$5.12K | ﹤0.01% | 4751 |
|
|
2019
Q4 | $164K | Buy |
41,774
+23,183
| +125% | +$137K | ﹤0.01% | 5070 |
|
|
2019
Q3 | $164K | Sell |
18,591
-399
| -2% | -$3.77K | ﹤0.01% | 5082 |
|
|
2019
Q2 | $175K | Sell |
18,990
-2,144
| -10% | -$16.2K | ﹤0.01% | 5050 |
|
|
2019
Q1 | $135K | Buy |
21,134
+603
| +3% | +$3.93K | ﹤0.01% | 5018 |
|
|
2018
Q4 | $193K | Buy |
20,531
+6,622
| +48% | +$99.6K | ﹤0.01% | 4934 |
|
|
2018
Q3 | $280K | Buy |
13,909
+572
| +4% | +$14.9K | ﹤0.01% | 4819 |
|
|
2018
Q2 | $389K | Sell |
13,337
-177
| -1% | -$5.46K | ﹤0.01% | 4645 |
|
|
2018
Q1 | $403K | Sell |
13,514
-1,170
| -8% | -$37.7K | ﹤0.01% | 4552 |
|
|
2017
Q4 | $473K | Sell |
14,684
-2,372
| -14% | -$77.5K | ﹤0.01% | 4442 |
|
|
2017
Q3 | $593K | Buy |
17,056
+119
| +0.7% | +$3.83K | ﹤0.01% | 4218 |
|
|
2017
Q2 | $504K | Buy |
16,937
+3,167
| +23% | +$90.8K | ﹤0.01% | 4216 |
|
|
2017
Q1 | $410K | Sell |
13,770
-172
| -1% | -$4.39K | ﹤0.01% | 4377 |
|
|
2016
Q4 | $244K | Sell |
13,942
-2,163
| -13% | -$41.5K | ﹤0.01% | 4653 |
|
|
2016
Q3 | $383K | Sell |
16,105
-2,055
| -11% | -$38.7K | ﹤0.01% | 4101 |
|
|
2016
Q2 | $290K | Buy |
18,160
+12,940
| +248% | +$232K | ﹤0.01% | 4209 |
|
|
2016
Q1 | $109K | Buy |
5,220
+906
| +21% | +$16.2K | ﹤0.01% | 4774 |
|
|
2015
Q4 | $116K | Buy |
4,314
+3
| +0.1% | +$82 | ﹤0.01% | 4816 |
|
|
2015
Q3 | $120K | Buy |
4,311
+658
| +18% | +$20.7K | ﹤0.01% | 4770 |
|
|
2015
Q2 | $89K | Buy |
3,653
+2,539
| +228% | +$52.3K | ﹤0.01% | 5128 |
|
|
2015
Q1 | $20K | Sell |
1,114
-2,241
| -67% | -$45.4K | ﹤0.01% | 5395 |
|
|
2014
Q4 | $62K | Hold |
3,355
| – | – | ﹤0.01% | 4939 |
|
|
2014
Q3 | $32K | Hold |
3,355
| – | – | ﹤0.01% | 5116 |
|
|
2014
Q2 | $31K | Sell |
3,355
-895
| -21% | -$8.17K | ﹤0.01% | 5176 |
|
|
2014
Q1 | $46K | Buy |
+4,250
| New | +$41.7K | ﹤0.01% | 4957 |
|
Wells Fargo's LJPC Position: Q3 2022 in Review
Wells Fargo sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 2,614 shares — an estimated $9K sold.
Wells Fargo first reported a position in LJPC in Q1 2014 and held it in 34 quarters. The position peaked at $1.58M in Q1 2021. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Wells Fargo reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Wells Fargo sold 2,614 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $9K.
- Wells Fargo first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 34 quarters.
- Wells Fargo's La Jolla Pharmaceutical Company position peaked at $1.58M in Q1 2021.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.